PLYMOUTH MEETING, Pa., Sept. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration (FDA) has ordered Baxter Healthcare Corporation to recall and destroy Colleague volumetric infusion pumps currently in use in the United States and to provide refunds or to replace pumps at no cost to customers to help defray the cost of replacement. Hospitals are starting the process of replacing their Colleague pumps; but many are unclear of the terms of the FDA announcement and have questions on how to best assess their options.
Replacing Colleague pumps may require establishing long-term relationships with the new pump supplier, which means heavily relying on them for initial implementation and ongoing support. Hospitals are asking questions like what are the terms of the recall and how do they impact us; what options are available to my facility; and how do I make the best choices for my clinicians, patients, and budget?
ECRI Institute’s Web Conference, “Replacing your Baxter Colleague Infusion Pump,” on September 22, 2010, from 1 to 2:30 p.m. ET, will provide a roadmap for facilities who are affected by the Baxter recall as well as other facilities who are in the market for new infusion pumps. There will be extended time for attendees to ask questions about the recall.
Presenters will also cover:
- Interpreting the announcements from Baxter and the FDA
- Best practices for choosing a replacement solution for your facility
- Planning ahead for a smooth transition to your new pumps
Speakers include:
- James P. Keller, Jr., MS, Moderator, Vice President, Health Technology Evaluation and Safety, ECRI Institute
- Brad Bonnette, Project Officer,Health Devices group, ECRI Institute
- Tim Ritter, Program Manager, Accident and Forensic Investigation group, ECRI Institute
- Erin Sparnon, Sr. Project Officer, Health Devices group, ECRI Institute
ECRI Institute will offer live updates from the event on Twitter at #BAX. All registrants will have access to the “Baxter recall discussion forum,” which encourages pre-web conference discussion on topics such as:
- What issues are you having at your facility with the Baxter recall?
- What are some alternatives to Baxter your facility is considering and why?
To learn more, or to register for this Web conference, visit www.ecri.org/webconference or contact ECRI Institute by telephone at (610) 825-6000, ext. 5889; by e-mail at circulation2@ecri.org; by fax at (610) 834-0240; or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA.
ECRI Institute, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes are best to enable improved patient care. As pioneers in this science for more than 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated a Collaborating Center of the World Health Organization and an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. For more information, visit https://www.ecri.org.
SOURCE ECRI Institute
